LIVN

LivaNova PLC (LIVN) LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea

4 days ago

LivaNova PLC (NASDAQ: LIVN) FY 2026 Other Release

2 weeks ago

LivaNova PLC (NASDAQ: LIVN) Q4 2025 Earnings Call dated Feb. 25, 2026 Corporate Participants: Briana Gotlin — Vice President, Investor…

4 weeks ago

LivaNova PLC (NASDAQ: LIVN) Q4 2025 Earnings Conference

4 weeks ago

LivaNova PLC (NASDAQ: LIVN) Q4 2025 Earnings Release

4 weeks ago

LivaNova PLC (NASDAQ: LIVN) FY 2026 Other Release

2 months ago

LivaNova PLC (NASDAQ: LIVN) Q2 2025 Earnings Call dated Aug. 06, 2025 Corporate Participants: Briana Gotlin — Vice President, Investor…

2 months ago

LivaNova PLC (NASDAQ: LIVN) Q3 2025 Earnings Call dated Nov. 05, 2025 Corporate Participants: Briana Gotlin — Vice President, Investor…

3 years ago

LivaNova PLC (NASDAQ: LIVN) Q3 2022 Earnings Conference

4 years ago

LivaNova PLC (NASDAQ: LIVN) Q2 2022 Earnings Conference

4 years ago

LivaNova PLC (NASDAQ: LIVN) Q1 2022 Earnings Conference